Nice! Would Pfizer be interested in us? “We assume they will...

Nice! Would Pfizer be interested in us?

“We assume they will look to continue to aggressively use their ‘COVID cash’ for bolt-on deals like Arena that can boost the company’s mid-late stage pipeline,” Divan wrote in a research note.”

Last time I checked we were mid to late stage.

Shows the potential value of our autoimmune candidate but it probably wouldn’t realize that value($5B) until late 2020’s when Imp 761 is in phase3. A few hurdles to jump before then.

Note. They only got an 80% increase on the share price which had been in decline for 12 months from its 5 year high in Oct 2020. So anyone buying at the high didn’t make anything on the takeover.

There’s a lesson here. BP don’t buy at the highs. They wait for the share price to tank and they probably help kick it down and smother any recoveries. Why wouldn’t they? They have the cash it’s easy for them and it saves them big bucks on the takeover price.

12 months of falling share price seems to be the sweet spot.

We need to wait until the Keytruda trial results mature. We are vulnerable next year without any major results due.